Journey Medical Corp Share Price Today: Live Updates & Key Insights

Journey Medical Corp share price today is $6.73, up -4.6%. The stock opened at $6.84 against the previous close of $6.95, with an intraday high of $6.97 and low of $6.63.

Journey Medical Corp Share Price Chart

Journey Medical Corp

us-stock
To Invest in {{usstockname}}
us-stock

Journey Medical Corp Share Price Performance

$6.73 -0.046(-4.6%) DERM at 23 Mar 2026 12:40 PM Drug Manufacturers - Specialty & Generic
Lowest Today 6.63
Highest Today 6.97
Today’s Open 6.84
Prev. Close 6.95
52 Week High 9.56
52 Week Low 5.51
Day’s Range: Low 6.63 High 6.97
52-Week Range: Low 5.51 High 9.56
1 day return -
1 Week return -10.88
1 month return -22.36
3 month return -17.33
6 month return -8.92
1 year return +2.95
3 year return +387.5
5 year return -30.35
10 year return -

Journey Medical Corp Institutional Holdings

TANG CAPITAL MANAGEMENT LLC 5.58

Wasatch Advisors LP 3.96

Opaleye Management Inc 2.93

J. Goldman & Co LP 2.40

Vanguard Group Inc 2.30

Wasatch Micro Cap Value 2.19

Wasatch Micro Cap Value Composite 2.19

BlackRock Inc 1.90

Millennium Management LLC 1.38

Pale Fire Capital SE 1.34

Vanguard Total Stock Mkt Idx Inv 1.30

Summit Financial, LLC 1.17

Essex Investment Management Company, LLC 1.04

iShares Russell 2000 ETF 0.96

Geode Capital Management, LLC 0.94

Renaissance Technologies Corp 0.73

American Financial Group Inc 0.54

State Street Corp 0.44

UBS Group AG 0.44

Fidelity Small Cap Index 0.43

Vanguard Institutional Extnd Mkt Idx Tr 0.42

Sheets Smith Investment Management 0.40

iShares Russell 2000 Growth ETF 0.37

Legato Capital Management LLC 0.34

Pleiades Small Cap Equity A 0.33

Northern Trust Corp 0.28

The Informed Momentum Company (formerly EAM Investors) 0.27

1290 Essex Small Cap Growth I 0.24

Fidelity Extended Market Index 0.22

Citadel Advisors Llc 0.21

Vanguard Russell 2000 ETF 0.21

State St Russell Sm Cap® Indx SL Cl I 0.13

iShares Micro-Cap ETF 0.11

Schwab Small Cap Index 0.11

NT R2000 Index Fund - NL 0.09

NT R2000 Index Fund - DC - NL - 3 0.08

Blackrock Extended Mkt Fund CF 0.07

Fidelity Total Market Index 0.07

iShares Russell 2000 Small-Cap Idx Instl 0.06

Extended Equity Market Fund K 0.06

Journey Medical Corp Market Status

Strong Buy: 3

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Journey Medical Corp Fundamentals

Market Cap 220.49 M

PB Ratio 8.5138

PE Ratio 0.0

Enterprise Value 220.84 M

Total Assets 80.24 M

Volume 998099

Journey Medical Corp Company Financials

Annual Revenue FY23:79890000 79.9M, FY22:73669000 73.7M, FY21:63134000 63.1M, FY20:44531000 44.5M, FY19:34921000 34.9M

Annual Profit FY23:51527000 51.5M, FY22:42894000 42.9M, FY21:31050000 31.1M, FY20:29937000 29.9M, FY19:24389000 24.4M

Annual Net worth FY23:-12352000 -12.4M, FY22:-29628000 -29.6M, FY21:-43994000 -44.0M, FY20:5283000 5.3M, FY19:3625000 3.6M

Quarterly Revenue Q3/2025:17631000 17.6M, Q2/2025:15009000 15.0M, Q1/2025:13139000 13.1M, Q3/2024:14629000 14.6M, Q2/2024:14855000 14.9M

Quarterly Profit Q3/2025:11876000 11.9M, Q2/2025:9006000 9.0M, Q1/2025:8349000 8.3M, Q3/2024:9344000 9.3M, Q2/2024:8314000 8.3M

Quarterly Net worth Q3/2025:-2315000 -2.3M, Q2/2025:-3796000 -3.8M, Q1/2025:-4073000 -4.1M, Q3/2024:-2390000 -2.4M, Q2/2024:-3361000 -3.4M

About Journey Medical Corp & investment objective

Company Information Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Organisation Drug Manufacturers - Specialty & Generic

Employees 41

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Claude Maraoui

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Journey Medical Corp FAQs

What is the share price of Journey Medical Corp today?

The current share price of Journey Medical Corp is $6.73.

Can I buy Journey Medical Corp shares in India?

Yes, Indian investors can buy Journey Medical Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy Journey Medical Corp shares in India?

You can easily invest in Journey Medical Corp shares from India by:

Can I buy fractional shares of Journey Medical Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Journey Medical Corp?

Journey Medical Corp has a market cap of $220.49 M.

In which sector does Journey Medical Corp belong?

Journey Medical Corp operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Journey Medical Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of Journey Medical Corp?

The PE ratio of Journey Medical Corp is N/A and the PB ratio is 8.51.